Artwork

Content provided by BioTech Nation Team and Moira Gunn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTech Nation Team and Moira Gunn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Psychedelics... Prodrugs... What else? Dr. Sam Clark, CEO of Terran Biosciences

17:48
 
Share
 

Manage episode 429339369 series 3360496
Content provided by BioTech Nation Team and Moira Gunn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTech Nation Team and Moira Gunn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.

  continue reading

94 episodes

Artwork
iconShare
 
Manage episode 429339369 series 3360496
Content provided by BioTech Nation Team and Moira Gunn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTech Nation Team and Moira Gunn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.

  continue reading

94 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide